

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | protein neddylation (GO:0045116) | 5.44872278 |
| 2 | neurofilament cytoskeleton organization (GO:0060052) | 4.56451068 |
| 3 | synaptic vesicle exocytosis (GO:0016079) | 4.43738751 |
| 4 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.41225890 |
| 5 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.39448831 |
| 6 | negative regulation of response to food (GO:0032096) | 4.23445108 |
| 7 | negative regulation of appetite (GO:0032099) | 4.23445108 |
| 8 | neurotransmitter secretion (GO:0007269) | 4.10458142 |
| 9 | vocalization behavior (GO:0071625) | 4.00478047 |
| 10 | synaptic vesicle maturation (GO:0016188) | 3.99537608 |
| 11 | phenol-containing compound catabolic process (GO:0019336) | 3.95307835 |
| 12 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.93988727 |
| 13 | glutamate secretion (GO:0014047) | 3.91702850 |
| 14 | adaptation of signaling pathway (GO:0023058) | 3.89380907 |
| 15 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.85068833 |
| 16 | cell migration in hindbrain (GO:0021535) | 3.82867077 |
| 17 | neuron cell-cell adhesion (GO:0007158) | 3.81512871 |
| 18 | locomotory exploration behavior (GO:0035641) | 3.75943396 |
| 19 | positive regulation of cAMP-mediated signaling (GO:0043950) | 3.74242450 |
| 20 | platelet dense granule organization (GO:0060155) | 3.70324575 |
| 21 | regulation of synaptic vesicle transport (GO:1902803) | 3.66281097 |
| 22 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.61409673 |
| 23 | sulfation (GO:0051923) | 3.54365058 |
| 24 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.53525218 |
| 25 | postsynaptic membrane organization (GO:0001941) | 3.51997556 |
| 26 | DNA deamination (GO:0045006) | 3.49851176 |
| 27 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.49412751 |
| 28 | signal complex assembly (GO:0007172) | 3.46607470 |
| 29 | dopamine transport (GO:0015872) | 3.46029406 |
| 30 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.45515724 |
| 31 | thrombin receptor signaling pathway (GO:0070493) | 3.44947063 |
| 32 | behavioral response to nicotine (GO:0035095) | 3.43333230 |
| 33 | regulation of cilium movement (GO:0003352) | 3.43089917 |
| 34 | neurotransmitter transport (GO:0006836) | 3.42901680 |
| 35 | behavioral response to ethanol (GO:0048149) | 3.41873575 |
| 36 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.39387366 |
| 37 | proline transport (GO:0015824) | 3.37680784 |
| 38 | definitive hemopoiesis (GO:0060216) | 3.33580027 |
| 39 | neuronal action potential (GO:0019228) | 3.33169705 |
| 40 | layer formation in cerebral cortex (GO:0021819) | 3.27992636 |
| 41 | negative regulation of heart rate (GO:0010459) | 3.27197243 |
| 42 | protein localization to synapse (GO:0035418) | 3.24002804 |
| 43 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.23236204 |
| 44 | neuronal action potential propagation (GO:0019227) | 3.23185844 |
| 45 | neurotransmitter catabolic process (GO:0042135) | 3.22252455 |
| 46 | exploration behavior (GO:0035640) | 3.21971638 |
| 47 | regulation of appetite (GO:0032098) | 3.18937950 |
| 48 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.15798025 |
| 49 | sympathetic nervous system development (GO:0048485) | 3.15259478 |
| 50 | neuromuscular process controlling posture (GO:0050884) | 3.14802276 |
| 51 | regulation of synapse structural plasticity (GO:0051823) | 3.12720817 |
| 52 | neuromuscular synaptic transmission (GO:0007274) | 3.11063160 |
| 53 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.10339082 |
| 54 | inositol phosphate catabolic process (GO:0071545) | 3.08063625 |
| 55 | cranial nerve structural organization (GO:0021604) | 3.07686328 |
| 56 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.07161100 |
| 57 | glycerophospholipid catabolic process (GO:0046475) | 3.03919235 |
| 58 | regulation of vesicle fusion (GO:0031338) | 3.03817410 |
| 59 | cell differentiation in hindbrain (GO:0021533) | 3.03567460 |
| 60 | serotonin metabolic process (GO:0042428) | 3.02841002 |
| 61 | nonmotile primary cilium assembly (GO:0035058) | 3.02340609 |
| 62 | facial nerve structural organization (GO:0021612) | 3.01935560 |
| 63 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.01165373 |
| 64 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.00931630 |
| 65 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.00440728 |
| 66 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.00245713 |
| 67 | response to pheromone (GO:0019236) | 2.99935003 |
| 68 | indolalkylamine metabolic process (GO:0006586) | 2.99636571 |
| 69 | L-fucose catabolic process (GO:0042355) | 2.99031584 |
| 70 | fucose catabolic process (GO:0019317) | 2.99031584 |
| 71 | L-fucose metabolic process (GO:0042354) | 2.99031584 |
| 72 | righting reflex (GO:0060013) | 2.98831137 |
| 73 | N-glycan processing (GO:0006491) | 2.98696126 |
| 74 | dendritic spine morphogenesis (GO:0060997) | 2.98620512 |
| 75 | piRNA metabolic process (GO:0034587) | 2.97534889 |
| 76 | regulation of neurotransmitter levels (GO:0001505) | 2.96283947 |
| 77 | catecholamine transport (GO:0051937) | 2.95666383 |
| 78 | positive regulation of membrane potential (GO:0045838) | 2.95528764 |
| 79 | startle response (GO:0001964) | 2.95171358 |
| 80 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.94476168 |
| 81 | amine catabolic process (GO:0009310) | 2.93831989 |
| 82 | cellular biogenic amine catabolic process (GO:0042402) | 2.93831989 |
| 83 | negative regulation of microtubule polymerization (GO:0031115) | 2.91586029 |
| 84 | cytidine metabolic process (GO:0046087) | 2.90693816 |
| 85 | cytidine catabolic process (GO:0006216) | 2.90693816 |
| 86 | cytidine deamination (GO:0009972) | 2.90693816 |
| 87 | regulation of neurotransmitter secretion (GO:0046928) | 2.90169930 |
| 88 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 2.89902156 |
| 89 | inositol phosphate dephosphorylation (GO:0046855) | 2.89902156 |
| 90 | positive regulation of meiosis (GO:0045836) | 2.86132459 |
| 91 | activation of protein kinase A activity (GO:0034199) | 2.85105249 |
| 92 | detection of calcium ion (GO:0005513) | 2.82653378 |
| 93 | protein-cofactor linkage (GO:0018065) | 2.80714709 |
| 94 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.80090813 |
| 95 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.80090813 |
| 96 | NADH dehydrogenase complex assembly (GO:0010257) | 2.80090813 |
| 97 | protein complex biogenesis (GO:0070271) | 2.79574795 |
| 98 | neuron recognition (GO:0008038) | 2.79510385 |
| 99 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.79484288 |
| 100 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.79359289 |
| 101 | negative regulation of mast cell activation (GO:0033004) | 2.79181343 |
| 102 | urinary tract smooth muscle contraction (GO:0014848) | 2.78449911 |
| 103 | behavioral response to cocaine (GO:0048148) | 2.77865223 |
| 104 | sequestering of actin monomers (GO:0042989) | 2.77847524 |
| 105 | regulation of microtubule-based movement (GO:0060632) | 2.77408137 |
| 106 | regulation of glycogen (starch) synthase activity (GO:2000465) | 2.76859638 |
| 107 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.76437850 |
| 108 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.76329878 |
| 109 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.76329878 |
| 110 | gamma-aminobutyric acid transport (GO:0015812) | 2.75995633 |
| 111 | primary amino compound metabolic process (GO:1901160) | 2.75174676 |
| 112 | detection of light stimulus involved in visual perception (GO:0050908) | 2.74801004 |
| 113 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.74801004 |
| 114 | regulation of neurotransmitter transport (GO:0051588) | 2.73968080 |
| 115 | membrane depolarization during action potential (GO:0086010) | 2.73024377 |
| 116 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.72772678 |
| 117 | epithelial cilium movement (GO:0003351) | 2.72028653 |
| 118 | rhodopsin mediated signaling pathway (GO:0016056) | 2.71732612 |
| 119 | male meiosis I (GO:0007141) | 2.71690744 |
| 120 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 2.71588080 |
| 121 | synaptic transmission, cholinergic (GO:0007271) | 2.71534764 |
| 122 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.71196171 |
| 123 | maternal behavior (GO:0042711) | 2.71074466 |
| 124 | regulation of response to food (GO:0032095) | 2.70874693 |
| 125 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.70412179 |
| 126 | mating behavior (GO:0007617) | 2.70350337 |
| 127 | synapse assembly (GO:0007416) | 2.70298023 |
| 128 | neuron-neuron synaptic transmission (GO:0007270) | 2.70008612 |
| 129 | indole-containing compound catabolic process (GO:0042436) | 2.69942303 |
| 130 | indolalkylamine catabolic process (GO:0046218) | 2.69942303 |
| 131 | tryptophan catabolic process (GO:0006569) | 2.69942303 |
| 132 | phospholipid scrambling (GO:0017121) | 2.69029761 |
| 133 | male meiosis (GO:0007140) | 2.68893755 |
| 134 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 2.68432889 |
| 135 | regulation of synaptic transmission, dopaminergic (GO:0032225) | 2.67382802 |
| 136 | negative regulation of dendrite development (GO:2000171) | 2.65976455 |
| 137 | cellular response to ATP (GO:0071318) | 2.65566610 |
| 138 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.65316072 |
| 139 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.64727515 |
| 140 | positive regulation of meiotic cell cycle (GO:0051446) | 2.64419990 |
| 141 | negative regulation of neurotransmitter transport (GO:0051589) | 2.63792528 |
| 142 | protein targeting to Golgi (GO:0000042) | 2.62751820 |
| 143 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.62386006 |
| 144 | regulation of meiosis I (GO:0060631) | 2.61721317 |
| 145 | presynaptic membrane assembly (GO:0097105) | 2.61115208 |
| 146 | indole-containing compound metabolic process (GO:0042430) | 2.61028595 |
| 147 | response to auditory stimulus (GO:0010996) | 2.60550800 |
| 148 | negative regulation of telomere maintenance (GO:0032205) | 2.60151620 |
| 149 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 2.60120914 |
| 150 | transmission of nerve impulse (GO:0019226) | 2.59565729 |
| 151 | tachykinin receptor signaling pathway (GO:0007217) | 2.59394147 |
| 152 | regulation of postsynaptic membrane potential (GO:0060078) | 2.59301796 |
| 153 | tryptophan metabolic process (GO:0006568) | 2.58893858 |
| 154 | regulation of respiratory system process (GO:0044065) | 2.58060438 |
| 155 | regulation of respiratory gaseous exchange (GO:0043576) | 2.56817572 |
| 156 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.55352949 |
| 157 | axoneme assembly (GO:0035082) | 2.55199170 |
| 158 | positive regulation of protein homodimerization activity (GO:0090073) | 2.54189765 |
| 159 | synaptic transmission, glutamatergic (GO:0035249) | 2.53604527 |
| 160 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.53176055 |
| 161 | kidney mesenchyme development (GO:0072074) | 2.53150399 |
| 162 | regulation of Rac protein signal transduction (GO:0035020) | 2.52812878 |
| 163 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.52761947 |
| 164 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.52650068 |
| 165 | auditory behavior (GO:0031223) | 2.51755866 |
| 166 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.51441786 |
| 167 | axon cargo transport (GO:0008088) | 2.51437573 |
| 168 | regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095) | 2.51204311 |
| 169 | centriole replication (GO:0007099) | 2.50883625 |
| 170 | synapsis (GO:0007129) | 2.49801755 |
| 171 | detection of mechanical stimulus involved in sensory perception (GO:0050974) | 2.47975915 |
| 172 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 2.47744796 |
| 173 | signal peptide processing (GO:0006465) | 2.46341143 |
| 174 | autophagic vacuole fusion (GO:0000046) | 2.46074807 |
| 175 | glutamate receptor signaling pathway (GO:0007215) | 2.45628623 |
| 176 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.44965706 |
| 177 | action potential (GO:0001508) | 2.44886608 |
| 178 | regulation of collateral sprouting (GO:0048670) | 2.44158263 |
| 179 | meiosis I (GO:0007127) | 2.44112743 |
| 180 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.42945909 |
| 181 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.42113942 |
| 182 | negative regulation of systemic arterial blood pressure (GO:0003085) | 2.40683223 |
| 183 | photoreceptor cell development (GO:0042461) | 2.39976832 |
| 184 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.39870989 |
| 185 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.38402868 |
| 186 | photoreceptor cell maintenance (GO:0045494) | 2.37636103 |
| 187 | phosphatidylethanolamine acyl-chain remodeling (GO:0036152) | 2.36882829 |
| 188 | response to amphetamine (GO:0001975) | 2.36725540 |
| 189 | serotonin receptor signaling pathway (GO:0007210) | 2.36339758 |
| 190 | regulation of platelet activation (GO:0010543) | 2.35872869 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.88741470 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.80877956 |
| 3 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 3.34069649 |
| 4 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.21779152 |
| 5 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.19303417 |
| 6 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 3.12797039 |
| 7 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.10704174 |
| 8 | VDR_22108803_ChIP-Seq_LS180_Human | 3.08326457 |
| 9 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.06710224 |
| 10 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.75849798 |
| 11 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.71063232 |
| 12 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.71063232 |
| 13 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.68152469 |
| 14 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.63749554 |
| 15 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.52043765 |
| 16 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.48524342 |
| 17 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.46808822 |
| 18 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.39477423 |
| 19 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.36631824 |
| 20 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.23606277 |
| 21 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.20524007 |
| 22 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.20019907 |
| 23 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.18634185 |
| 24 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.15757756 |
| 25 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.15354096 |
| 26 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.07308680 |
| 27 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.05406806 |
| 28 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.03530710 |
| 29 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.02937721 |
| 30 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.02875982 |
| 31 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 2.01184985 |
| 32 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.97787782 |
| 33 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.85203309 |
| 34 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.84596654 |
| 35 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.82736369 |
| 36 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.80946167 |
| 37 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.78903316 |
| 38 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.74731453 |
| 39 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.73125569 |
| 40 | FUS_26573619_Chip-Seq_HEK293_Human | 1.68855710 |
| 41 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.67204900 |
| 42 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.66454852 |
| 43 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.65597449 |
| 44 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.64729516 |
| 45 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.63200195 |
| 46 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.58761824 |
| 47 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.54012241 |
| 48 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.53720381 |
| 49 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.53187261 |
| 50 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.52935519 |
| 51 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.50202954 |
| 52 | * RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.50106791 |
| 53 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.49133565 |
| 54 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.48721545 |
| 55 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.48521897 |
| 56 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.48213877 |
| 57 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.45525077 |
| 58 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.44802981 |
| 59 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.41927110 |
| 60 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.41191774 |
| 61 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.39774646 |
| 62 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.38725681 |
| 63 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.38314679 |
| 64 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.37071685 |
| 65 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.36821257 |
| 66 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.34667921 |
| 67 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.34433587 |
| 68 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.32775409 |
| 69 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.32695860 |
| 70 | TP53_16413492_ChIP-PET_HCT116_Human | 1.32684249 |
| 71 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.29886546 |
| 72 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.29441777 |
| 73 | * NANOG_19829295_ChIP-Seq_ESCs_Human | 1.27255441 |
| 74 | * SOX2_19829295_ChIP-Seq_ESCs_Human | 1.27255441 |
| 75 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.23069284 |
| 76 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.23069284 |
| 77 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.22989279 |
| 78 | STAT3_23295773_ChIP-Seq_U87_Human | 1.22408691 |
| 79 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.20976384 |
| 80 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.20423208 |
| 81 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.20275151 |
| 82 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.19975365 |
| 83 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.18704570 |
| 84 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.18704570 |
| 85 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.17826777 |
| 86 | AR_25329375_ChIP-Seq_VCAP_Human | 1.16858696 |
| 87 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.16820938 |
| 88 | * HTT_18923047_ChIP-ChIP_STHdh_Human | 1.16581390 |
| 89 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.15826650 |
| 90 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.15391888 |
| 91 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.14183252 |
| 92 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.14030165 |
| 93 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.13901488 |
| 94 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.13712628 |
| 95 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.13712628 |
| 96 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.12769625 |
| 97 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.12286813 |
| 98 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.11923273 |
| 99 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.11814870 |
| 100 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.11659995 |
| 101 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.11410945 |
| 102 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.10984698 |
| 103 | * TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.10825610 |
| 104 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.09015792 |
| 105 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.08729298 |
| 106 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.08112621 |
| 107 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.07746614 |
| 108 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.07618586 |
| 109 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.07414435 |
| 110 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.06411787 |
| 111 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.06373539 |
| 112 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.05976311 |
| 113 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.05425885 |
| 114 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.05410109 |
| 115 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.05177886 |
| 116 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.05162359 |
| 117 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.03759853 |
| 118 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.03352820 |
| 119 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.02722920 |
| 120 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.01622688 |
| 121 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.01589163 |
| 122 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.01332649 |
| 123 | NCOR_22424771_ChIP-Seq_293T_Human | 1.00893098 |
| 124 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.00784043 |
| 125 | JUN_21703547_ChIP-Seq_K562_Human | 0.99983059 |
| 126 | TBL1_22424771_ChIP-Seq_293T_Human | 0.98326570 |
| 127 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 0.98011639 |
| 128 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.97039159 |
| 129 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.96407505 |
| 130 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.96112275 |
| 131 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.95855029 |
| 132 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.94876733 |
| 133 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.93077108 |
| 134 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.93069255 |
| 135 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.91914811 |
| 136 | KDM2B_26808549_Chip-Seq_REH_Human | 0.91310387 |
| 137 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.91039107 |
| 138 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.90667030 |
| 139 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.90094693 |
| 140 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.88987211 |
| 141 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.88333919 |
| 142 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.86952221 |
| 143 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.86183336 |
| 144 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.84577269 |
| 145 | EWS_26573619_Chip-Seq_HEK293_Human | 0.83679320 |
| 146 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.83231349 |
| 147 | AR_19668381_ChIP-Seq_PC3_Human | 0.82832343 |
| 148 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.82135921 |
| 149 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.81819143 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 3.99689644 |
| 2 | MP0002822_catalepsy | 3.94001241 |
| 3 | MP0003880_abnormal_central_pattern | 3.73886503 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 3.21803291 |
| 5 | MP0004270_analgesia | 3.06997367 |
| 6 | MP0003122_maternal_imprinting | 2.89481054 |
| 7 | MP0005464_abnormal_platelet_physiology | 2.87319061 |
| 8 | MP0000569_abnormal_digit_pigmentation | 2.85237623 |
| 9 | MP0008877_abnormal_DNA_methylation | 2.69847890 |
| 10 | MP0009745_abnormal_behavioral_response | 2.66785565 |
| 11 | MP0009046_muscle_twitch | 2.64901877 |
| 12 | MP0004885_abnormal_endolymph | 2.47062016 |
| 13 | MP0009379_abnormal_foot_pigmentation | 2.45772202 |
| 14 | MP0006276_abnormal_autonomic_nervous | 2.43785663 |
| 15 | MP0002063_abnormal_learning/memory/cond | 2.36725963 |
| 16 | MP0005551_abnormal_eye_electrophysiolog | 2.34323747 |
| 17 | MP0010386_abnormal_urinary_bladder | 2.30711832 |
| 18 | MP0003787_abnormal_imprinting | 2.29029651 |
| 19 | MP0002064_seizures | 2.28286478 |
| 20 | MP0002734_abnormal_mechanical_nocicepti | 2.22850768 |
| 21 | MP0002102_abnormal_ear_morphology | 2.21058291 |
| 22 | MP0002272_abnormal_nervous_system | 2.20481132 |
| 23 | MP0002572_abnormal_emotion/affect_behav | 2.20451260 |
| 24 | MP0001968_abnormal_touch/_nociception | 2.14891081 |
| 25 | MP0001188_hyperpigmentation | 2.07889491 |
| 26 | MP0001486_abnormal_startle_reflex | 2.05533777 |
| 27 | MP0003195_calcinosis | 2.01110796 |
| 28 | MP0002733_abnormal_thermal_nociception | 2.00494887 |
| 29 | MP0001501_abnormal_sleep_pattern | 2.00300313 |
| 30 | MP0002184_abnormal_innervation | 1.93453502 |
| 31 | MP0008569_lethality_at_weaning | 1.93231330 |
| 32 | MP0005646_abnormal_pituitary_gland | 1.88035913 |
| 33 | MP0005084_abnormal_gallbladder_morpholo | 1.87416257 |
| 34 | MP0002638_abnormal_pupillary_reflex | 1.82441127 |
| 35 | MP0003283_abnormal_digestive_organ | 1.79350864 |
| 36 | MP0000372_irregular_coat_pigmentation | 1.78062097 |
| 37 | MP0001905_abnormal_dopamine_level | 1.74459984 |
| 38 | MP0001440_abnormal_grooming_behavior | 1.73461614 |
| 39 | MP0002735_abnormal_chemical_nociception | 1.72661895 |
| 40 | MP0000778_abnormal_nervous_system | 1.70708072 |
| 41 | MP0005386_behavior/neurological_phenoty | 1.70471998 |
| 42 | MP0004924_abnormal_behavior | 1.70471998 |
| 43 | MP0002557_abnormal_social/conspecific_i | 1.68213877 |
| 44 | MP0001986_abnormal_taste_sensitivity | 1.64849301 |
| 45 | MP0005174_abnormal_tail_pigmentation | 1.64785555 |
| 46 | MP0001970_abnormal_pain_threshold | 1.62169648 |
| 47 | MP0003011_delayed_dark_adaptation | 1.60113087 |
| 48 | MP0005623_abnormal_meninges_morphology | 1.57550934 |
| 49 | MP0002067_abnormal_sensory_capabilities | 1.57488712 |
| 50 | MP0000230_abnormal_systemic_arterial | 1.56030694 |
| 51 | MP0003136_yellow_coat_color | 1.55124702 |
| 52 | MP0000955_abnormal_spinal_cord | 1.54292938 |
| 53 | MP0003279_aneurysm | 1.53861608 |
| 54 | MP0009780_abnormal_chondrocyte_physiolo | 1.50074503 |
| 55 | MP0004811_abnormal_neuron_physiology | 1.48166663 |
| 56 | MP0005083_abnormal_biliary_tract | 1.44894305 |
| 57 | MP0004742_abnormal_vestibular_system | 1.43392383 |
| 58 | MP0005410_abnormal_fertilization | 1.43099427 |
| 59 | MP0001485_abnormal_pinna_reflex | 1.42424842 |
| 60 | MP0002751_abnormal_autonomic_nervous | 1.40801315 |
| 61 | MP0001348_abnormal_lacrimal_gland | 1.40179841 |
| 62 | MP0002736_abnormal_nociception_after | 1.38473423 |
| 63 | MP0006292_abnormal_olfactory_placode | 1.37323784 |
| 64 | MP0002909_abnormal_adrenal_gland | 1.35742649 |
| 65 | MP0008004_abnormal_stomach_pH | 1.34510808 |
| 66 | MP0003121_genomic_imprinting | 1.33609026 |
| 67 | MP0001270_distended_abdomen | 1.32324761 |
| 68 | MP0004130_abnormal_muscle_cell | 1.32138298 |
| 69 | MP0004858_abnormal_nervous_system | 1.30999566 |
| 70 | MP0000015_abnormal_ear_pigmentation | 1.29945004 |
| 71 | MP0003638_abnormal_response/metabolism_ | 1.29024029 |
| 72 | MP0005423_abnormal_somatic_nervous | 1.27984123 |
| 73 | MP0001529_abnormal_vocalization | 1.22593875 |
| 74 | MP0002876_abnormal_thyroid_physiology | 1.22103226 |
| 75 | MP0009278_abnormal_bone_marrow | 1.21178261 |
| 76 | MP0004215_abnormal_myocardial_fiber | 1.19282830 |
| 77 | MP0004133_heterotaxia | 1.17331677 |
| 78 | MP0004145_abnormal_muscle_electrophysio | 1.15076411 |
| 79 | MP0004142_abnormal_muscle_tone | 1.14460410 |
| 80 | MP0005253_abnormal_eye_physiology | 1.14168227 |
| 81 | MP0002160_abnormal_reproductive_system | 1.13942185 |
| 82 | MP0005389_reproductive_system_phenotype | 1.13638487 |
| 83 | MP0002066_abnormal_motor_capabilities/c | 1.13122056 |
| 84 | MP0008775_abnormal_heart_ventricle | 1.12649399 |
| 85 | MP0002882_abnormal_neuron_morphology | 1.11794074 |
| 86 | MP0004085_abnormal_heartbeat | 1.10471942 |
| 87 | MP0002837_dystrophic_cardiac_calcinosis | 1.09607937 |
| 88 | MP0003718_maternal_effect | 1.07131870 |
| 89 | MP0008875_abnormal_xenobiotic_pharmacok | 1.06923171 |
| 90 | MP0002089_abnormal_postnatal_growth/wei | 1.06111625 |
| 91 | MP0003646_muscle_fatigue | 1.05364365 |
| 92 | MP0000427_abnormal_hair_cycle | 1.04340461 |
| 93 | MP0001984_abnormal_olfaction | 1.03597492 |
| 94 | MP0000751_myopathy | 1.03443624 |
| 95 | MP0000538_abnormal_urinary_bladder | 1.02125599 |
| 96 | MP0010329_abnormal_lipoprotein_level | 1.00436887 |
| 97 | MP0002163_abnormal_gland_morphology | 0.99042674 |
| 98 | MP0005310_abnormal_salivary_gland | 0.98781494 |
| 99 | MP0003698_abnormal_male_reproductive | 0.97392832 |
| 100 | MP0006072_abnormal_retinal_apoptosis | 0.96462250 |
| 101 | MP0003633_abnormal_nervous_system | 0.96342545 |
| 102 | MP0001664_abnormal_digestion | 0.96250034 |
| 103 | MP0000013_abnormal_adipose_tissue | 0.95323425 |
| 104 | MP0005167_abnormal_blood-brain_barrier | 0.92974971 |
| 105 | MP0001919_abnormal_reproductive_system | 0.92569607 |
| 106 | MP0000026_abnormal_inner_ear | 0.92341086 |
| 107 | MP0003879_abnormal_hair_cell | 0.91243250 |
| 108 | MP0008995_early_reproductive_senescence | 0.90868561 |
| 109 | MP0002653_abnormal_ependyma_morphology | 0.90394499 |
| 110 | MP0005379_endocrine/exocrine_gland_phen | 0.90278008 |
| 111 | MP0005409_darkened_coat_color | 0.90189816 |
| 112 | MP0000631_abnormal_neuroendocrine_gland | 0.89825606 |
| 113 | MP0006036_abnormal_mitochondrial_physio | 0.88332442 |
| 114 | MP0002210_abnormal_sex_determination | 0.87921913 |
| 115 | MP0005645_abnormal_hypothalamus_physiol | 0.87784454 |
| 116 | MP0003724_increased_susceptibility_to | 0.87694748 |
| 117 | MP0003959_abnormal_lean_body | 0.86141909 |
| 118 | MP0002152_abnormal_brain_morphology | 0.85946023 |
| 119 | MP0005448_abnormal_energy_balance | 0.85924923 |
| 120 | MP0002229_neurodegeneration | 0.84655567 |
| 121 | MP0001943_abnormal_respiration | 0.84399191 |
| 122 | MP0005636_abnormal_mineral_homeostasis | 0.84162476 |
| 123 | MP0000534_abnormal_ureter_morphology | 0.81070713 |
| 124 | MP0003942_abnormal_urinary_system | 0.81044889 |
| 125 | MP0001929_abnormal_gametogenesis | 0.79446576 |
| 126 | MP0003137_abnormal_impulse_conducting | 0.79072037 |
| 127 | MP0005195_abnormal_posterior_eye | 0.78714755 |
| 128 | MP0001299_abnormal_eye_distance/ | 0.77536585 |
| 129 | MP0001765_abnormal_ion_homeostasis | 0.75891220 |
| 130 | MP0001879_abnormal_lymphatic_vessel | 0.75209369 |
| 131 | MP0002928_abnormal_bile_duct | 0.74635524 |
| 132 | MP0002234_abnormal_pharynx_morphology | 0.72855734 |
| 133 | MP0002938_white_spotting | 0.71280568 |
| 134 | MP0001177_atelectasis | 0.70315000 |
| 135 | MP0004147_increased_porphyrin_level | 0.70101745 |
| 136 | MP0003631_nervous_system_phenotype | 0.69656012 |
| 137 | MP0001502_abnormal_circadian_rhythm | 0.67619533 |
| 138 | MP0010770_preweaning_lethality | 0.67164737 |
| 139 | MP0002082_postnatal_lethality | 0.67164737 |
| 140 | MP0002095_abnormal_skin_pigmentation | 0.65478202 |
| 141 | MP0001958_emphysema | 0.65143433 |
| 142 | MP0002752_abnormal_somatic_nervous | 0.64850097 |
| 143 | MP0002177_abnormal_outer_ear | 0.62332854 |
| 144 | MP0010769_abnormal_survival | 0.61572705 |
| 145 | MP0002693_abnormal_pancreas_physiology | 0.59094415 |
| 146 | MP0002108_abnormal_muscle_morphology | 0.59050492 |
| 147 | MP0001963_abnormal_hearing_physiology | 0.58194950 |
| 148 | MP0008872_abnormal_physiological_respon | 0.58109873 |
| 149 | MP0001944_abnormal_pancreas_morphology | 0.57874777 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 5.91022063 |
| 2 | Agitation (HP:0000713) | 4.88648342 |
| 3 | Progressive cerebellar ataxia (HP:0002073) | 4.86215179 |
| 4 | Myokymia (HP:0002411) | 4.85070221 |
| 5 | Hypothermia (HP:0002045) | 4.78980277 |
| 6 | Visual hallucinations (HP:0002367) | 4.41307487 |
| 7 | Prolonged bleeding time (HP:0003010) | 4.36181404 |
| 8 | Focal seizures (HP:0007359) | 3.88747262 |
| 9 | Febrile seizures (HP:0002373) | 3.71957550 |
| 10 | Asymmetry of the thorax (HP:0001555) | 3.68513640 |
| 11 | Abnormality of midbrain morphology (HP:0002418) | 3.61534764 |
| 12 | Molar tooth sign on MRI (HP:0002419) | 3.61534764 |
| 13 | Pancreatic fibrosis (HP:0100732) | 3.60452284 |
| 14 | Pancreatic cysts (HP:0001737) | 3.58974555 |
| 15 | Petechiae (HP:0000967) | 3.55789563 |
| 16 | Ulnar claw (HP:0001178) | 3.52610895 |
| 17 | True hermaphroditism (HP:0010459) | 3.51398301 |
| 18 | Increased mean platelet volume (HP:0011877) | 3.49487842 |
| 19 | Congenital stationary night blindness (HP:0007642) | 3.47850782 |
| 20 | Decreased central vision (HP:0007663) | 3.44300429 |
| 21 | Limb dystonia (HP:0002451) | 3.40204245 |
| 22 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.40187276 |
| 23 | Action tremor (HP:0002345) | 3.23010484 |
| 24 | Papilledema (HP:0001085) | 3.21351940 |
| 25 | Genetic anticipation (HP:0003743) | 3.18848545 |
| 26 | Menorrhagia (HP:0000132) | 3.17025869 |
| 27 | Atonic seizures (HP:0010819) | 3.12721742 |
| 28 | Abnormal platelet volume (HP:0011876) | 3.11735781 |
| 29 | Thyroiditis (HP:0100646) | 3.09593160 |
| 30 | Nephronophthisis (HP:0000090) | 3.04010646 |
| 31 | Abolished electroretinogram (ERG) (HP:0000550) | 3.02077931 |
| 32 | Scanning speech (HP:0002168) | 2.99063706 |
| 33 | Broad-based gait (HP:0002136) | 2.94970502 |
| 34 | Poikilocytosis (HP:0004447) | 2.93420836 |
| 35 | Abnormality of B cell number (HP:0010975) | 2.92417447 |
| 36 | B lymphocytopenia (HP:0010976) | 2.92417447 |
| 37 | Abnormality of the renal cortex (HP:0011035) | 2.90590055 |
| 38 | 3-Methylglutaconic aciduria (HP:0003535) | 2.86001529 |
| 39 | Hypoplasia of the thymus (HP:0000778) | 2.83897176 |
| 40 | Progressive inability to walk (HP:0002505) | 2.83872292 |
| 41 | Mutism (HP:0002300) | 2.81393810 |
| 42 | Truncal ataxia (HP:0002078) | 2.78995966 |
| 43 | Epileptic encephalopathy (HP:0200134) | 2.78565872 |
| 44 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.73747039 |
| 45 | Potter facies (HP:0002009) | 2.73309548 |
| 46 | Facial shape deformation (HP:0011334) | 2.73309548 |
| 47 | Medial flaring of the eyebrow (HP:0010747) | 2.70579993 |
| 48 | Hyperlipoproteinemia (HP:0010980) | 2.70137850 |
| 49 | Generalized tonic-clonic seizures (HP:0002069) | 2.69439692 |
| 50 | Hypoventilation (HP:0002791) | 2.66829929 |
| 51 | Supernumerary spleens (HP:0009799) | 2.60809244 |
| 52 | Abnormality of the renal medulla (HP:0100957) | 2.57803572 |
| 53 | Panhypogammaglobulinemia (HP:0003139) | 2.57187059 |
| 54 | Hypoproteinemia (HP:0003075) | 2.56259061 |
| 55 | Amblyopia (HP:0000646) | 2.56230792 |
| 56 | Gait imbalance (HP:0002141) | 2.56213629 |
| 57 | Failure to thrive in infancy (HP:0001531) | 2.55163402 |
| 58 | Exotropia (HP:0000577) | 2.54924282 |
| 59 | Hyperventilation (HP:0002883) | 2.52391668 |
| 60 | Purpura (HP:0000979) | 2.51153330 |
| 61 | Macroorchidism (HP:0000053) | 2.50938343 |
| 62 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.49764573 |
| 63 | Congenital, generalized hypertrichosis (HP:0004540) | 2.48206815 |
| 64 | Tubulointerstitial fibrosis (HP:0005576) | 2.45186350 |
| 65 | Acute necrotizing encephalopathy (HP:0006965) | 2.45169133 |
| 66 | Progressive macrocephaly (HP:0004481) | 2.45042177 |
| 67 | Renal cortical cysts (HP:0000803) | 2.44644158 |
| 68 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.41782184 |
| 69 | Absence seizures (HP:0002121) | 2.35014816 |
| 70 | Attenuation of retinal blood vessels (HP:0007843) | 2.34578882 |
| 71 | Congenital sensorineural hearing impairment (HP:0008527) | 2.31692187 |
| 72 | Pendular nystagmus (HP:0012043) | 2.30034104 |
| 73 | Acanthocytosis (HP:0001927) | 2.29979391 |
| 74 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.27620934 |
| 75 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.27620934 |
| 76 | Restlessness (HP:0000711) | 2.25820094 |
| 77 | Male pseudohermaphroditism (HP:0000037) | 2.24186553 |
| 78 | Drooling (HP:0002307) | 2.23948188 |
| 79 | Excessive salivation (HP:0003781) | 2.23948188 |
| 80 | Poor eye contact (HP:0000817) | 2.23595279 |
| 81 | Gaze-evoked nystagmus (HP:0000640) | 2.22964056 |
| 82 | Hypercortisolism (HP:0001578) | 2.22705616 |
| 83 | Protruding tongue (HP:0010808) | 2.21853349 |
| 84 | Epistaxis (HP:0000421) | 2.18660818 |
| 85 | Impaired smooth pursuit (HP:0007772) | 2.18270246 |
| 86 | Furrowed tongue (HP:0000221) | 2.18085641 |
| 87 | Upper limb muscle weakness (HP:0003484) | 2.16466011 |
| 88 | Testicular neoplasm (HP:0010788) | 2.15931437 |
| 89 | Abnormal hair whorl (HP:0010721) | 2.15665058 |
| 90 | Abnormality of alanine metabolism (HP:0010916) | 2.14587203 |
| 91 | Hyperalaninemia (HP:0003348) | 2.14587203 |
| 92 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.14587203 |
| 93 | Type II lissencephaly (HP:0007260) | 2.14516981 |
| 94 | Congenital primary aphakia (HP:0007707) | 2.14515777 |
| 95 | Polydipsia (HP:0001959) | 2.13913632 |
| 96 | Mitochondrial inheritance (HP:0001427) | 2.10615912 |
| 97 | Cystic liver disease (HP:0006706) | 2.09600338 |
| 98 | Abnormal ciliary motility (HP:0012262) | 2.09518418 |
| 99 | Sclerocornea (HP:0000647) | 2.08643535 |
| 100 | Acute encephalopathy (HP:0006846) | 2.08559593 |
| 101 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.08372222 |
| 102 | Absent/shortened dynein arms (HP:0200106) | 2.08372222 |
| 103 | Dialeptic seizures (HP:0011146) | 2.06852675 |
| 104 | Renal Fanconi syndrome (HP:0001994) | 2.06757425 |
| 105 | Impaired social interactions (HP:0000735) | 2.06644178 |
| 106 | Abnormal social behavior (HP:0012433) | 2.06644178 |
| 107 | Abnormal eating behavior (HP:0100738) | 2.05365389 |
| 108 | Genital tract atresia (HP:0001827) | 2.05341044 |
| 109 | Tubulointerstitial abnormality (HP:0001969) | 2.04921694 |
| 110 | Nephrogenic diabetes insipidus (HP:0009806) | 2.04868886 |
| 111 | Paralysis (HP:0003470) | 2.01629996 |
| 112 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.01461779 |
| 113 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 2.00792357 |
| 114 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.00560499 |
| 115 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.00560499 |
| 116 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.98612281 |
| 117 | Anxiety (HP:0000739) | 1.98491035 |
| 118 | Vaginal atresia (HP:0000148) | 1.98266485 |
| 119 | Generalized hypopigmentation of hair (HP:0011358) | 1.96830364 |
| 120 | Decreased circulating renin level (HP:0003351) | 1.96714039 |
| 121 | Infantile muscular hypotonia (HP:0008947) | 1.96522613 |
| 122 | Chronic hepatic failure (HP:0100626) | 1.94286048 |
| 123 | Inability to walk (HP:0002540) | 1.93753951 |
| 124 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.91773306 |
| 125 | Menstrual irregularities (HP:0000858) | 1.91148164 |
| 126 | Polyphagia (HP:0002591) | 1.89825786 |
| 127 | Lower limb amyotrophy (HP:0007210) | 1.89749034 |
| 128 | Tubulointerstitial nephritis (HP:0001970) | 1.89660456 |
| 129 | Steppage gait (HP:0003376) | 1.88738497 |
| 130 | Optic nerve hypoplasia (HP:0000609) | 1.87966039 |
| 131 | Increased CSF lactate (HP:0002490) | 1.87900931 |
| 132 | Diplopia (HP:0000651) | 1.87403790 |
| 133 | Abnormality of binocular vision (HP:0011514) | 1.87403790 |
| 134 | Dysmetric saccades (HP:0000641) | 1.86682761 |
| 135 | Tubular atrophy (HP:0000092) | 1.85882074 |
| 136 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.85195874 |
| 137 | Large for gestational age (HP:0001520) | 1.84670455 |
| 138 | Fair hair (HP:0002286) | 1.84393440 |
| 139 | Radial bowing (HP:0002986) | 1.84251863 |
| 140 | Long toe (HP:0010511) | 1.84163646 |
| 141 | Short nail (HP:0001799) | 1.83953858 |
| 142 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.83741892 |
| 143 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.83661983 |
| 144 | Long nose (HP:0003189) | 1.83451228 |
| 145 | Polyuria (HP:0000103) | 1.82875465 |
| 146 | Pachygyria (HP:0001302) | 1.82723824 |
| 147 | Ankle clonus (HP:0011448) | 1.81966680 |
| 148 | Dysdiadochokinesis (HP:0002075) | 1.81628221 |
| 149 | Abnormality of renal resorption (HP:0011038) | 1.80350336 |
| 150 | Ventricular fibrillation (HP:0001663) | 1.80247699 |
| 151 | Stomatitis (HP:0010280) | 1.80237445 |
| 152 | Thyroid-stimulating hormone excess (HP:0002925) | 1.79816742 |
| 153 | Abnormal pupillary function (HP:0007686) | 1.78698206 |
| 154 | Anencephaly (HP:0002323) | 1.77538018 |
| 155 | Lissencephaly (HP:0001339) | 1.77379585 |
| 156 | Dyschromatopsia (HP:0007641) | 1.77355529 |
| 157 | Methylmalonic acidemia (HP:0002912) | 1.73725250 |
| 158 | Lower limb muscle weakness (HP:0007340) | 1.73561566 |
| 159 | Hammertoe (HP:0001765) | 1.72918113 |
| 160 | Hemiparesis (HP:0001269) | 1.72222691 |
| 161 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.71030036 |
| 162 | Stereotypic behavior (HP:0000733) | 1.70925696 |
| 163 | Optic disc pallor (HP:0000543) | 1.70185830 |
| 164 | Abnormality of the labia minora (HP:0012880) | 1.68852919 |
| 165 | Hemiplegia (HP:0002301) | 1.66193867 |
| 166 | Hyperparathyroidism (HP:0000843) | 1.64020615 |
| 167 | Broad metatarsal (HP:0001783) | 1.63709747 |
| 168 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.63490232 |
| 169 | Enlarged penis (HP:0000040) | 1.63225995 |
| 170 | Retinal dysplasia (HP:0007973) | 1.62824580 |
| 171 | EEG with generalized epileptiform discharges (HP:0011198) | 1.62568368 |
| 172 | Neuroendocrine neoplasm (HP:0100634) | 1.62411189 |
| 173 | Depression (HP:0000716) | 1.61873052 |
| 174 | Pheochromocytoma (HP:0002666) | 1.61635354 |
| 175 | Epileptiform EEG discharges (HP:0011182) | 1.60178276 |
| 176 | Peripheral hypomyelination (HP:0007182) | 1.60039337 |
| 177 | Decreased muscle mass (HP:0003199) | 1.59984310 |
| 178 | Myotonia (HP:0002486) | 1.59505110 |
| 179 | Fragile skin (HP:0001030) | 1.58961884 |
| 180 | Abnormal drinking behavior (HP:0030082) | 1.58458819 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K4 | 4.25105735 |
| 2 | NTRK3 | 3.77151665 |
| 3 | MAP2K7 | 3.32708758 |
| 4 | MARK1 | 3.23532217 |
| 5 | NTRK1 | 3.03542304 |
| 6 | BMPR1B | 2.67272057 |
| 7 | MAP4K2 | 2.37052336 |
| 8 | PINK1 | 2.36026303 |
| 9 | MAP3K9 | 2.35439893 |
| 10 | MINK1 | 2.35045705 |
| 11 | MST4 | 2.33816127 |
| 12 | ZAK | 2.19005894 |
| 13 | TNIK | 2.09647175 |
| 14 | CAMKK2 | 2.09095468 |
| 15 | FRK | 2.05435443 |
| 16 | GRK1 | 2.01675092 |
| 17 | MUSK | 1.98801337 |
| 18 | NUAK1 | 1.98073425 |
| 19 | LATS2 | 1.95951774 |
| 20 | CASK | 1.86461004 |
| 21 | ACVR1B | 1.72463926 |
| 22 | MAP2K4 | 1.70043240 |
| 23 | DYRK2 | 1.66158390 |
| 24 | PAK3 | 1.56820381 |
| 25 | LMTK2 | 1.56162175 |
| 26 | GRK5 | 1.51506796 |
| 27 | TLK1 | 1.51395448 |
| 28 | DAPK2 | 1.49461872 |
| 29 | TRIM28 | 1.46775049 |
| 30 | TAOK3 | 1.45563085 |
| 31 | CAMKK1 | 1.44769533 |
| 32 | WNK1 | 1.41556469 |
| 33 | TXK | 1.36478586 |
| 34 | PDGFRA | 1.35353196 |
| 35 | MAPK13 | 1.33033919 |
| 36 | NTRK2 | 1.31931990 |
| 37 | WNK3 | 1.26799581 |
| 38 | ERBB3 | 1.25449527 |
| 39 | PTK2B | 1.25209536 |
| 40 | NME1 | 1.24431623 |
| 41 | EIF2AK1 | 1.23582118 |
| 42 | RIPK4 | 1.22987076 |
| 43 | MAP3K12 | 1.21570050 |
| 44 | PHKG2 | 1.17264532 |
| 45 | PHKG1 | 1.17264532 |
| 46 | PAK6 | 1.16159697 |
| 47 | GRK7 | 1.14763647 |
| 48 | PRKCE | 1.12336891 |
| 49 | BMX | 1.07989699 |
| 50 | CDK19 | 1.07527567 |
| 51 | PRKCH | 1.05781086 |
| 52 | STK16 | 1.03359536 |
| 53 | MATK | 1.02892903 |
| 54 | CDK5 | 1.01449235 |
| 55 | RPS6KB2 | 0.99501977 |
| 56 | PKN1 | 0.99310425 |
| 57 | YES1 | 0.96595915 |
| 58 | CAMK1G | 0.96416269 |
| 59 | TSSK6 | 0.94390876 |
| 60 | PLK2 | 0.91647808 |
| 61 | AKT3 | 0.91469253 |
| 62 | STK38 | 0.91396376 |
| 63 | SYK | 0.90837830 |
| 64 | STK39 | 0.89697104 |
| 65 | PRKCG | 0.87311553 |
| 66 | STK3 | 0.85718306 |
| 67 | ADRBK1 | 0.82714506 |
| 68 | TNK2 | 0.82446976 |
| 69 | DMPK | 0.81979778 |
| 70 | FGR | 0.78835834 |
| 71 | SGK2 | 0.77621291 |
| 72 | PNCK | 0.75725205 |
| 73 | TAF1 | 0.75316580 |
| 74 | OXSR1 | 0.74892012 |
| 75 | PIK3CG | 0.74545172 |
| 76 | UHMK1 | 0.74038021 |
| 77 | PRKG2 | 0.72986519 |
| 78 | PTK2 | 0.72147414 |
| 79 | MKNK2 | 0.72113414 |
| 80 | HIPK2 | 0.70500505 |
| 81 | PDGFRB | 0.70112868 |
| 82 | CAMK2A | 0.69594433 |
| 83 | RPS6KA5 | 0.69079020 |
| 84 | SGK223 | 0.68977613 |
| 85 | SGK494 | 0.68977613 |
| 86 | EPHB2 | 0.67531040 |
| 87 | MAPKAPK5 | 0.67420713 |
| 88 | INSRR | 0.67193024 |
| 89 | VRK1 | 0.66097091 |
| 90 | CAMK1 | 0.66059315 |
| 91 | PRKCQ | 0.65518865 |
| 92 | FGFR3 | 0.64478267 |
| 93 | FES | 0.64395087 |
| 94 | RPS6KA2 | 0.63296286 |
| 95 | TIE1 | 0.62508650 |
| 96 | RPS6KB1 | 0.61202834 |
| 97 | SIK2 | 0.60565279 |
| 98 | BTK | 0.59315766 |
| 99 | CSNK1E | 0.56807360 |
| 100 | CSNK1G2 | 0.56767951 |
| 101 | PRKG1 | 0.56729747 |
| 102 | CSNK1A1L | 0.56462854 |
| 103 | PAK2 | 0.56162544 |
| 104 | ITK | 0.55074510 |
| 105 | IGF1R | 0.54700355 |
| 106 | STK11 | 0.54428835 |
| 107 | MYLK | 0.54423348 |
| 108 | MAP2K1 | 0.53380105 |
| 109 | CAMK1D | 0.53093201 |
| 110 | RET | 0.52753809 |
| 111 | FGFR1 | 0.52390603 |
| 112 | MARK2 | 0.50736250 |
| 113 | CDC42BPA | 0.50320296 |
| 114 | MAPK15 | 0.49195328 |
| 115 | BRSK2 | 0.48296302 |
| 116 | WNK4 | 0.48060564 |
| 117 | ADRBK2 | 0.47613183 |
| 118 | PLK3 | 0.47468072 |
| 119 | PRKCZ | 0.45573801 |
| 120 | PRKACA | 0.45442971 |
| 121 | CSNK1G3 | 0.45386705 |
| 122 | BMPR2 | 0.44989600 |
| 123 | PIK3CA | 0.44974862 |
| 124 | BCKDK | 0.43165009 |
| 125 | DDR2 | 0.42678655 |
| 126 | FYN | 0.42559947 |
| 127 | TEC | 0.42364324 |
| 128 | MAPKAPK3 | 0.42306110 |
| 129 | RPS6KA3 | 0.42164910 |
| 130 | IKBKB | 0.41649587 |
| 131 | PRKD3 | 0.41467374 |
| 132 | DAPK1 | 0.41297690 |
| 133 | CSNK1G1 | 0.40791012 |
| 134 | PRKCB | 0.40735323 |
| 135 | CCNB1 | 0.40724892 |
| 136 | MAP2K6 | 0.40457145 |
| 137 | PRKCA | 0.39700648 |
| 138 | RAF1 | 0.39674001 |
| 139 | CDK14 | 0.39529636 |
| 140 | INSR | 0.37506752 |
| 141 | ROCK1 | 0.37096403 |
| 142 | DYRK1A | 0.37017087 |
| 143 | LIMK1 | 0.36992395 |
| 144 | PRKACG | 0.35835660 |
| 145 | SGK1 | 0.35227150 |
| 146 | ERBB2 | 0.35164098 |
| 147 | TAOK1 | 0.34448500 |
| 148 | PLK4 | 0.34410441 |
| 149 | FGFR2 | 0.34030308 |
| 150 | TGFBR1 | 0.32696166 |
| 151 | PRKCI | 0.31327747 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 2.86792786 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.86400589 |
| 3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.72819445 |
| 4 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.42525057 |
| 5 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.42103480 |
| 6 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.37229931 |
| 7 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.29966812 |
| 8 | GABAergic synapse_Homo sapiens_hsa04727 | 2.18837008 |
| 9 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.16423309 |
| 10 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.13474508 |
| 11 | Long-term potentiation_Homo sapiens_hsa04720 | 2.12474749 |
| 12 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.09638683 |
| 13 | Serotonergic synapse_Homo sapiens_hsa04726 | 2.09464559 |
| 14 | Cocaine addiction_Homo sapiens_hsa05030 | 2.07562694 |
| 15 | Circadian entrainment_Homo sapiens_hsa04713 | 2.07363200 |
| 16 | Morphine addiction_Homo sapiens_hsa05032 | 1.99539740 |
| 17 | Insulin secretion_Homo sapiens_hsa04911 | 1.96957708 |
| 18 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.91582175 |
| 19 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.90561753 |
| 20 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.85298207 |
| 21 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.85148460 |
| 22 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.78283189 |
| 23 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.75367370 |
| 24 | Long-term depression_Homo sapiens_hsa04730 | 1.75061828 |
| 25 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.73041398 |
| 26 | Olfactory transduction_Homo sapiens_hsa04740 | 1.64337492 |
| 27 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.61187352 |
| 28 | Taste transduction_Homo sapiens_hsa04742 | 1.57416454 |
| 29 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.49537142 |
| 30 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.48816791 |
| 31 | Renin secretion_Homo sapiens_hsa04924 | 1.47780624 |
| 32 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.47242950 |
| 33 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.46736072 |
| 34 | Homologous recombination_Homo sapiens_hsa03440 | 1.45396636 |
| 35 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.44433364 |
| 36 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.40102729 |
| 37 | Salivary secretion_Homo sapiens_hsa04970 | 1.39411470 |
| 38 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.37209583 |
| 39 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.34595188 |
| 40 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.33589010 |
| 41 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.32273972 |
| 42 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.31820661 |
| 43 | Basal transcription factors_Homo sapiens_hsa03022 | 1.28966494 |
| 44 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.28505222 |
| 45 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.28173894 |
| 46 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.26443204 |
| 47 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.25547308 |
| 48 | Huntingtons disease_Homo sapiens_hsa05016 | 1.25427998 |
| 49 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.24149978 |
| 50 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.24016110 |
| 51 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.20582860 |
| 52 | Axon guidance_Homo sapiens_hsa04360 | 1.20504065 |
| 53 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.18196475 |
| 54 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.16964907 |
| 55 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.16399329 |
| 56 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.15041431 |
| 57 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.14956564 |
| 58 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.11100980 |
| 59 | Gap junction_Homo sapiens_hsa04540 | 1.08457052 |
| 60 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.07794880 |
| 61 | Glioma_Homo sapiens_hsa05214 | 1.00681178 |
| 62 | Melanoma_Homo sapiens_hsa05218 | 1.00204766 |
| 63 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.98887831 |
| 64 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.98248703 |
| 65 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.97184693 |
| 66 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.96789800 |
| 67 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.95876895 |
| 68 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.94160069 |
| 69 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.93936378 |
| 70 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.93224020 |
| 71 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.91912005 |
| 72 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.91506654 |
| 73 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.90964844 |
| 74 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.89919572 |
| 75 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.88541494 |
| 76 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.87676351 |
| 77 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.87504218 |
| 78 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.87409985 |
| 79 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.86556038 |
| 80 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.86512231 |
| 81 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.86108391 |
| 82 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.86061744 |
| 83 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.85023073 |
| 84 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.84765240 |
| 85 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.84587395 |
| 86 | RNA polymerase_Homo sapiens_hsa03020 | 0.84351816 |
| 87 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.83381749 |
| 88 | Platelet activation_Homo sapiens_hsa04611 | 0.81323806 |
| 89 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.79850456 |
| 90 | Melanogenesis_Homo sapiens_hsa04916 | 0.79534183 |
| 91 | ABC transporters_Homo sapiens_hsa02010 | 0.78023552 |
| 92 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.77535724 |
| 93 | Parkinsons disease_Homo sapiens_hsa05012 | 0.77070284 |
| 94 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.76282244 |
| 95 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.75777513 |
| 96 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.75563404 |
| 97 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.75146104 |
| 98 | Alzheimers disease_Homo sapiens_hsa05010 | 0.73938597 |
| 99 | Retinol metabolism_Homo sapiens_hsa00830 | 0.73161256 |
| 100 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.72773639 |
| 101 | Peroxisome_Homo sapiens_hsa04146 | 0.69665040 |
| 102 | Focal adhesion_Homo sapiens_hsa04510 | 0.69282007 |
| 103 | Phototransduction_Homo sapiens_hsa04744 | 0.68821614 |
| 104 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.67363241 |
| 105 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.67193833 |
| 106 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.67006912 |
| 107 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.66012557 |
| 108 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.65310524 |
| 109 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.64850080 |
| 110 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.64055467 |
| 111 | Alcoholism_Homo sapiens_hsa05034 | 0.63582162 |
| 112 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.60844661 |
| 113 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.60388813 |
| 114 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.58077152 |
| 115 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.57615111 |
| 116 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.56190834 |
| 117 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.55675262 |
| 118 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.55416889 |
| 119 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.54964750 |
| 120 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.54756461 |
| 121 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.52831129 |
| 122 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.52150482 |
| 123 | Mineral absorption_Homo sapiens_hsa04978 | 0.50748230 |
| 124 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.50472946 |
| 125 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.50457350 |
| 126 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.50081773 |
| 127 | Shigellosis_Homo sapiens_hsa05131 | 0.48981836 |
| 128 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.47791868 |
| 129 | Purine metabolism_Homo sapiens_hsa00230 | 0.47156075 |
| 130 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.46257977 |
| 131 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.45520421 |
| 132 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.45447116 |
| 133 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.45407442 |
| 134 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.45294419 |
| 135 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.43611859 |
| 136 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.42892348 |
| 137 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.42152397 |
| 138 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.40552583 |
| 139 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.39083898 |
| 140 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.39034300 |
| 141 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.38853511 |
| 142 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.37583083 |
| 143 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.37336623 |
| 144 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.37055106 |
| 145 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.37023631 |
| 146 | Protein export_Homo sapiens_hsa03060 | 0.36282676 |
| 147 | Metabolic pathways_Homo sapiens_hsa01100 | 0.36264346 |
| 148 | RNA degradation_Homo sapiens_hsa03018 | 0.34956857 |
| 149 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.34275952 |
| 150 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.33425798 |
| 151 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.32409965 |

